日本恶性血液病分子遗传学的发展课件（英文）.pptVIP

“The molecular genetic development of hematologic malignancy in Japan” ;Disclosure of COI;Today’s talk;Clinical practice of Non-Hodgkin’s Lymphoma (B-cell lymphoma) in CIH;DLBCL : treatment result by CHOP±Rituximab ;87 cases treated by CHOP and 141 cases treated by RCHOP Were analized in DLBCL.;RCHOP was superior to CHOP in both;RCHOP is superior to CHOP, and sIL-2R is still good marker For prognosis. ;;;;The principle of imaging-based CDC susceptibility assay;Diagnostic details of patients evaluated for CDC susceptibility;Correlation between CDC and clinical response ;Reproducible ADCC assa